Correlation Between Milestone Pharmaceuticals and Sera Prognostics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Sera Prognostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Sera Prognostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Sera Prognostics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Sera Prognostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Sera Prognostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Sera Prognostics.
Diversification Opportunities for Milestone Pharmaceuticals and Sera Prognostics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Milestone and Sera is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Sera Prognostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sera Prognostics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Sera Prognostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sera Prognostics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Sera Prognostics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Sera Prognostics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.66 times more return on investment than Sera Prognostics. However, Milestone Pharmaceuticals is 1.52 times less risky than Sera Prognostics. It trades about 0.07 of its potential returns per unit of risk. Sera Prognostics is currently generating about -0.01 per unit of risk. If you would invest 150.00 in Milestone Pharmaceuticals on June 26, 2024 and sell it today you would earn a total of 4.00 from holding Milestone Pharmaceuticals or generate 2.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Milestone Pharmaceuticals vs. Sera Prognostics
Performance |
Timeline |
Milestone Pharmaceuticals |
Sera Prognostics |
Milestone Pharmaceuticals and Sera Prognostics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Milestone Pharmaceuticals and Sera Prognostics
The main advantage of trading using opposite Milestone Pharmaceuticals and Sera Prognostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Sera Prognostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sera Prognostics will offset losses from the drop in Sera Prognostics' long position.Milestone Pharmaceuticals vs. PetIQ Inc | Milestone Pharmaceuticals vs. Emergent Biosolutions | Milestone Pharmaceuticals vs. Neurocrine Biosciences | Milestone Pharmaceuticals vs. Haleon plc |
Sera Prognostics vs. HCW Biologics | Sera Prognostics vs. RenovoRx | Sera Prognostics vs. Scpharmaceuticals | Sera Prognostics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |